Skip to main content

Non-CME Professional Medical Education (PME) Symposia


PME Breakfast Symposium (Non-CME)
Thursday, October 23 | 7:00 AM - 8:00 AM
A Triad of Diseases: A Treatment Strategy for Patients With T2D, CVD, and CKD

Davida F. Kruger, MSN, APN-BC,BC-ADM
 
Sponsored by Novo Nordisk.


Program Description:

 

 

PME Lunch Symposium (Non-CME)
Thursday, October 23 | 11:30 AM – 12:30 PM
Aldosterone as an underlying driver of hypertension and CV and kidney

Surendra Sivarajah, MD; Justin Fongemie, PharmD, BCCP

 

Sponsored by AstraZeneca.

 

Program Description:

Information is coming soon.


 
PME Dinner Symposium (Non-CME)
Thursday, October 23 | 6:15 PM - 7:15 PM
Tirzepatide: A Dual GIP and GLP-1 Receptor Agonist


Sponsored by Lilly.

 

Program Description: 
Learn about tirzepatide, a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist, the active ingredient in Zepbound® (tirzepatide) and Mounjaro® (tirzepatide). In this program, we will review clinical efficacy, safety, and dosing and administration information about Zepbound and Mounjaro.

 

Attendees will have the opportunity to ask questions to the speaker at the conclusion of the program.


 
PME Breakfast Symposium (Non-CME)
Friday, October 24 | 6:45 AM – 7:45 AM


Sponsored by Corcept Therapeutics.

 

Program Description:
Information is coming soon.


 
PME Lunch Symposium (Non-CME)
Friday, October 24 | 12:30 PM – 1:30 PM


Sponsored by Novo Nordisk.

 

Program Description:

Information is coming soon.



PME Dinner Symposium (Non-CME)
Friday, October 24 | 6:30 PM - 7:30 PM
Evidence-Based Treatment of Recurrent Pericarditis

 

John Ryan, MD


Sponsored by Kiniksa Pharmaceuticals.

 

Program Description:

Information coming soon.
 
 
PME Breakfast Symposium (Non-CME)
Saturday, October 25 | 7:00 AM – 8:00 AM


Sponsored by Arrowhead Pharmaceuticals.
 

Program Description:

Information is coming soon.